USFDA issues CRL for proposed biosimilar Pegfilgrastim: Biocon News News / News 6 years ago 492 Views comments This product is a part of the biosimilars portfolio being developed jointly by Biocon and Mylan. "The US Food and Drug Administration has issued a CRL... Read more
News India#39;s plan for higher rate luxury car tax to hit sales: Mercedes-Benz News / News - 6 years ago
News Options trading: Use ratios to take away hurdles between you and the direction News / News - 5 years ago
Comments